Journal of Neuroimmunology
Volume 221, Issue 1 , Pages 46-52 , 15 April 2010

Inhibition of C5a receptor alleviates experimental CNS lupus

  • Alexander Jacob

      Affiliations

    • Department of Medicine, University of Chicago, Chicago, IL 60637, United States
    • ,
  • Bradley Hack

      Affiliations

    • Department of Medicine, University of Chicago, Chicago, IL 60637, United States
    • ,
  • Tao Bai

      Affiliations

    • Department of Neurology, University of Chicago, Chicago, IL 60637, United States
    • ,
  • James R. Brorson

      Affiliations

    • Department of Neurology, University of Chicago, Chicago, IL 60637, United States
    • ,
  • Richard J. Quigg

      Affiliations

    • Department of Medicine, University of Chicago, Chicago, IL 60637, United States
    • ,
  • Jessy J. Alexander

      Affiliations

    • Department of Medicine, University of Chicago, Chicago, IL 60637, United States
    • Corresponding Author InformationCorresponding author. Department of Medicine, University of Chicago, 5841 South Maryland Avenue, MC5100, Chicago, IL 60637, United States.

Received 10 December 2009 ,Revised 11 February 2010 ,Accepted 11 February 2010.

References 

  1. Abbott NJ, Mendonca LL, Dolman DE. The blood–brain barrier in systemic lupus erythematosus. Lupus. 2003;12:908–915
  2. Abramson S, Belmont HM, Hopkins P, Buyon J, Winchester R, Weissmann G. Complement activation and vascular injury in systemic lupus erythematosus. J. Rheumatol. Suppl. 1987;14(Suppl 13):43–46
  3. Adachi M, Watanabe-Fukunaga R, Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. U. S. A. 1993;90:1756–1760
  4. Alexander JJ, Quigg RJ. Systemic lupus erythematosus and the brain: what mice are telling us. Neurochem. Int. 2007;50:5–11
  5. Alexander JJ, Bao L, Jacob A, Kraus DM, Holers VM, Quigg RJ. Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis. Biochim. Biophys. Acta. 2003;1639:169–176
  6. Alexander JJ, Jacob A, Bao L, MacDonald RL, Quigg RJ. Complement-dependent apoptosis and inflammatory gene changes in murine lupus cerebritis. J. Immunol. 2005;175:8312–8319
  7. Alexander JJ, Zwingmann C, Quigg R. MRL/lpr mice have alterations in brain metabolism as shown with [(1)H-(13)C] NMR spectroscopy. Neurochem. Int. 2005;47:143–151
  8. Alexander JJ, Jacob A, Vezina P, Sekine H, Gilkeson GS, Quigg RJ. Absence of functional alternative complement pathway alleviates lupus cerebritis. Eur. J. Immunol. 2007;37:1691–1701
  9. Alexander JJ, Anderson AJ, Barnum SR, Stevens B, Tenner AJ. The complement cascade: Yin–Yang in neuroinflammation––neuro-protection and -degeneration. J. Neurochem. 2008;107:1169–1187
  10. Alexander JJ, Jacob A, Cunningham P, Hensley L, Quigg RJ. TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem. Int. 2008;52:447–456
  11. Arora V, Verma J, Dutta R, Marwah V, Kumar A, Das N. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus. Mol. Immunol. 2004;41:449–456
  12. Ballok DA, Millward JM, Sakic B. Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining. Brain Res. 2003;964:200–210
  13. Bao L, Osawe I, Puri T, Lambris JD, Haas M, Quigg RJ. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. Eur. J. Immunol. 2005;35:2496–2506
  14. Bao L, Osawe I, Puri T, Lambris JD, Haas M, Quigg RJ. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. Eur. J. Immunol. 2005;35:2496–2506
  15. Baraczka K, Nekam K, Pozsonyi T, Jakab L, Szongoth M, Sesztak M. Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement. Neuroimmunomodulation. 2001;9:49–54
  16. Barnum SR. Complement biosynthesis in the central nervous system. Crit. Rev. Oral Biol. Med. 1995;6:132–146
  17. Belmont HM, Hopkins P, Edelson HS, Kaplan HB, Ludewig R, Weissmann G, et al. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease. Arthritis Rheum. 1986;29:1085–1089
  18. Brey RL, Sakic B, Szechtman H, Denburg JA. Animal models for nervous system disease in systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 1997;823:97–106
  19. Carroll MC, Fischer MB. Complement and the immune response. Curr. Opin. Immunol. 1997;9:64–69
  20. Diamond B, Volpe B. On the track of neuropsychiatric lupus. Arthritis Rheum. 2003;48:2710–2712
  21. Diamond B, Kowal C, Huerta PT, Aranow C, Mackay M, DeGiorgio LA, et al. Immunity and acquired alterations in cognition and emotion: lessons from SLE. Adv. Immunol. 2006;89:289–320
  22. Fonseca MI, Ager RR, Chu SH, Yazan O, Sanderson SD, LaFerla FM, et al. Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease. J. Immunol. 2009;183:1375–1383
  23. Fosbrink M, Niculescu F, Rus V, Shin ML, Rus H. C5b-9-induced endothelial cell proliferation and migration are dependent on Akt inactivation of forkhead transcription factor FOXO1. J. Biol. Chem. 2006;281:19009–19018
  24. Gabai VL, Meriin AB, Yaglom JA, Volloch VZ, Sherman MY. Role of Hsp70 in regulation of stress-kinase JNK: implications in apoptosis and aging. FEBS Lett. 1998;438:1–4
  25. Gasque P, Singhrao SK, Neal JW, Gotze O, Morgan BP. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 1997;150:31–41
  26. Gasque P, Singhrao SK, Neal JW, Wang P, Sayah S, Fontaine M, et al. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis. J. Immunol. 1998;160:3543–3554
  27. Guo RF, Riedemann NC, Ward PA. Role of C5a–C5aR interaction in sepsis. Shock. 2004;21:1–7
  28. Hill HD, Straka JG. Protein determination using bicinchoninic acid in the presence of sulfhydryl reagents. Anal. Biochem. 1988;170:203–208
  29. Huber-Lang MS, Riedeman NC, Sarma JV, Younkin EM, McGuire SR, Laudes IJ, et al. Protection of innate immunity by C5aR antagonist in septic mice. FASEB J. 2002;16:1567–1574
  30. Jacob A, Hensley LK, Safratowich BD, Quigg RJ, Alexander JJ. The role of the complement cascade in endotoxin-induced septic encephalopathy. Lab Invest. 2007;87:1186–1194
  31. Jacob A, Bao L, Brorson J, Quigg RJ, Alexander JJ. C3aR inhibition reduces neurodegeneration in experimental lupus. Lupus. 2009;19:73–82
  32. Johnston RB. The complement system in host defense and inflammation: the cutting edges of a double edged sword. Pediatr. Infect. Dis. J. 1993;12:933–941
  33. Kuan CY, Whitmarsh AJ, Yang DD, Liao G, Schloemer AJ, Dong C, et al. A critical role of neural-specific JNK3 for ischemic apoptosis. Proc. Natl. Acad. Sci. U. S. A. 2003;100:15184–15189
  34. Langkabel P, Zwirner J, Oppermann M. Ligand-induced phosphorylation of anaphylatoxin receptors C3aR and C5aR is mediated by ″G protein-coupled receptor kinases. Eur. J. Immunol. 1999;29:3035–3046
  35. Li D, Marks JD, Schumacker PT, Young RM, Brorson JR. Physiological hypoxia promotes survival of cultured cortical neurons. Eur. J. Neurosci. 2005;22:1319–1326
  36. Morgan BP, Gasque P. Expression of complement in the brain: role in health and disease. Immunol. Today. 1996;17:461–466
  37. Muller-Eberhard HJ. Molecular organization and function of the complement system. Annu. Rev. Biochem. 1988;57:321–347
  38. Nadeau S, Rivest S. The complement system is an integrated part of the natural innate immune response in the brain. FASEB J. 2001;15:1410–1412
  39. Niculescu T, Weerth S, Soane L, Niculescu F, Rus V, Raine CS, et al. Effects of membrane attack complex of complement on apoptosis in experimental autoimmune encephalomyelitis. Ann. N. Y. Acad. Sci. 2003;1010:530–533
  40. Niculescu T, Weerth S, Niculescu F, Cudrici C, Rus V, Raine CS, et al. Effects of complement C5 on apoptosis in experimental autoimmune encephalomyelitis. J. Immunol. 2004;172:5702–5706
  41. Niculescu T, Weerth S, Niculescu F, Cudrici C, Rus V, Raine CS, et al. Effects of complement C5 on apoptosis in experimental autoimmune encephalomyelitis. J. Immunol. 2004;172:5702–5706
  42. Norman MU, James WG, Hickey MJ. Differential roles of ICAM-1 and VCAM-1 in leukocyte-endothelial cell interactions in skin and brain of MRL/faslpr mice. J. Leukoc. Biol. 2008;84:68–76
  43. Sakic B, Szechtman H, Denburg JA. Neurobehavioral alterations in autoimmune mice. Neurosci. Biobehav. Rev. 1997;21:327–340
  44. Sakic B, Maric I, Koeberle PD, Millward JM, Szechtman H, Maric D, et al. Increased TUNEL staining in brains of autoimmune Fas-deficient mice. J. Neuroimmunol. 2000;104:147–154
  45. Sayah S, Patte C, Gasque P, Chan P, Ischenko A, Vaudry H, et al. Characterization of rat C5a anaphylatoxin receptor (C5aR): cloning of rat C5aR cDNA and study of C5aR expression by rat astrocytes. Brain Res. Mol. Brain Res. 1997;48:215–222
  46. Soane L, Cho HJ, Niculescu F, Rus H, Shin ML. C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway. J. Immunol. 2001;167:2305–2311
  47. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, et al. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science. 2000;288:870–874
  48. van Beek J, Elward K, Gasque P. Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann. N. Y. Acad. Sci. 2003;992:56–71
  49. Wang J, Ouyang C, Chen X, Fu B, Lu Y, Hong Q. Effect of Jak2 kinase inhibition on Stat1 and Stat3 activation and apoptosis of tubular epithelial cells induced by ATP depletion/recovery. J. Nephrol. 2008;21:919–923
  50. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992;356:314–317
  51. Weerth SH, Rus H, Shin ML, Raine CS. Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis. Am. J. Pathol. 2003;163:1069–1080
  52. Wesemann DR, Qin H, Kokorina N, Benveniste EN. TRADD interacts with STAT1-alpha and influences interferon-gamma signaling. Nat. Immunol. 2004;5:199–207
  53. Zipfel PF. Complement and immune defense: from innate immunity to human diseases. Immunol. Lett. 2009;126:1–7
  54. Zykova TA, Zhang Y, Zhu F, Bode AM, Dong Z. The signal transduction networks required for phosphorylation of STAT1 at Ser727 in mouse epidermal JB6 cells in the UVB response and inhibitory mechanisms of tea polyphenols. Carcinogenesis. 2005;26:331–342

PII: S0165-5728(10)00060-3

doi: 10.1016/j.jneuroim.2010.02.011

Journal of Neuroimmunology
Volume 221, Issue 1 , Pages 46-52 , 15 April 2010

Article Tools

* Image Usage & Resolution